Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Establishing Correlates of Maternal-Fetal Cytomegalovirus Transmission—One Step Closer Through Predictive Modeling.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Marchant, Arnaud; Adali, Sancar; Alsdurf, Hannah; Bol, Vanesa; Capelle, Xavier; Schrevel, Nathalie De; Delroisse, Jean-Marc; Devlieger, Roland; Dieussaert, Ilse; Donner, Catherine; Janssens, Michel; Loquet, Philip; Panackal, Anil A; Seidl, Claudia; Berg, Robert A van den; Paris, Robert
- Source:
Journal of Infectious Diseases; 12/15/2024, Vol. 230 Issue 6, pe1274-e1286, 13p
- Subject Terms:
- Additional Information
- Abstract:
Background Determinants of maternal-fetal cytomegalovirus (CMV) transmission and factors influencing the severity of congenital CMV (cCMV) infection are not well understood. Methods We conducted a descriptive, multicenter study in pregnant women ≥18 years old with primary CMV infection and their newborns to explore maternal immune responses to CMV and determine potential immunologic/virologic correlates of cCMV following primary infection during pregnancy. We developed alternative approaches looking into univariate/multivariate factors associated with cCMV, including a participant clustering/stratification approach and an interpretable predictive model–based approach using trained decision trees for risk prediction (post hoc analyses). Results Pregnant women were grouped in 3 distinct clusters with similar baseline characteristics, particularly gestational age at diagnosis. We observed a trend for higher viral loads in urine and saliva samples from mothers of infants with cCMV versus without cCMV. When using a trained predictive-model approach that accounts for interaction effects between variables, anti-pentamer immunoglobulin G antibody concentration and viral load in saliva were identified as biomarkers jointly associated with the risk of maternal-fetal CMV transmission. Conclusions We identified biomarkers of CMV maternal-fetal transmission. After validation in larger studies, our findings will guide the management of primary infection during pregnancy and the development of vaccines against cCMV. Clinical Trials Registration NCT01251744. [ABSTRACT FROM AUTHOR]
- Abstract:
Copyright of Journal of Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.